Gabapentin in the treatment of epilepsy in the elderly;Gabapentina en el tratamiento de la epilepsia del anciano

Revista de Neurologia

Volumn 34, Issue 4, 2002, Pages 391-396

  Gil Nagel, Antonio ^a  

^a HOSPITAL RUBER INTERNACIONAL   (Spain)

Author keywords

Antiepileptic drugs; Epilepsy in the elderly; Gabapentin; Renal failure

Indexed keywords

ALLOPURINOL; AMIODARONE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CIMETIDINE; DEXTROPROPOXYPHENE; DILTIAZEM; ERYTHROMYCIN; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; ISONIAZID; LAMOTRIGINE; NORTRIPTYLINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PROPRANOLOL; RIFAMPICIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VERAPAMIL; VIGABATRIN;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DRUG METABOLISM; DRUG PROTEIN BINDING; EPILEPSY; GERIATRIC CARE; HUMAN; KIDNEY FAILURE; NEUROLOGIC DISEASE;

EID: 0037116720     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3404.2001500     Document Type: Article

References (44)

1. How common are epileptic seizures in old age?
2. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984
3. National General Practice Study of Epilepsy: Newly diagnosed epileptic seizures in a general population
4. A survey of epileptic disorders in southwest France: Seizures in elderly patients
5. Epilepsy in a population of 6000 re-examined: Secular trends in first attendance rates, prevalence, and prognosis
6. Proposal for revised classification of epilepsies and epileptic syndromes
7. Evidence of vascular disease from CT scanning in late onset epilepsy
8. Metabolism of antiepileptic medication: Newborn to elderly
9. Pharmacokinetics of valproic acid in the elderly
10. Valproic acid clearence: Unbound fraction and diurnal variations in young and elderly adults
11. Altered protein binding of diphenylhydantoin in uremic plasma
12. Displacement of phenytoin from plasma binding sites by salicylate
13. The effect of age on the pharmacokinetics of diazepam
14. Specific pharmacokinetic and pharmacodynamic problems of anticonvulsant drugs in the elderly
15. Pharmacokinetics of diazepam from a controlled release capsule in healthy elderly volunteers
16. Age and phenytoin kinetics in adult epileptics
17. The disposition of primidone in elderly patients
18. Remission of epilepsy: Results from the National General Practice Study of Epilepsy
19. Increaseed sensitivity to nitrazepam in old age
20. Reversible parkinsonism and cognitive impairment with chronic valproate use
21. Drug treatment as a cause of falls in old age. A review of the offending agents
22. Folate nutrition in the elderly
23. Hiponatremia during carbamazepine therapy
24. Epidemiology of adverse reactions to carbamazepine as seen in spontaneous reporting
25. Antiepileptic drug use in elderly patients with epilepsy
26. Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics
27. Antiepileptic drugs. A review of clinically significant drug interactions
28. Gabapentin
29. Antiepileptic drugs in the elderly: The place of gabapentin
30. Clinical pharmacokinetics of gabapentin
31. Effect of Maalox TC on single-dose pharmacokinetics of gabapentin capsules in healthy subjets
32. The tolerability and safety profile of gabapentin
33. Effects of age and gender in single-dose pharmacokinetics of gabapentin
34. Prediction of creatinine clearance from serum creatinine
35. Gabapentin: Clinical use
36. A multicenter, randomized, double-blind, comparative doseinitiation study of gabapentin (CI-945) in the elderly
37. Rapid initiation of gabapentin: A randomized, controlled trial
38. Safety of gabapentin vs valproic acid as add-on therapy to carbamazepine
39. Comparative cognitive effects of carbamacepina and gabapentina in healthy senior adults
40. Monotherapic use of gabapentin in newly diagnosed epilepsy in elderly: An open study in a genetically homogeneous population in Sardinia (Italy)
41. Efficacy of gabapentina (Neurontin) as add-on therapy for patients older than age 60 with partial epilepsy
42. Gabapentin in the treatment of vascular epilepsies
43. Evaluation of the efficacy and tolerability of gabapentin in poststroke epilepsy
44. Clinical experience with gabapentin (Neurontin) as monotherapy or adjunctive therapy in partial epilepsy secondary to neoplastic or vascular lesions